INTS

Intensity Therapeutics, Inc. Common stock

Price

$3.90

return (12m)

-37.28%

p/e

-9.44

p/bv

11.44

DIVIDEND YIELD

0.00%

INTS price

Intensity Therapeutics, Inc. Common stock

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INTS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-15.51%

3 months

-0.64%

1 year

-37.28%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals INTS

Valuation

P/E

-9.44

Sector 7.84

Industry 7.84

P/BV

11.44

Sector 1.84

Industry 1.84

P/Revenue (PSR)

-4,054.71

Sector 1.78

Industry 1.78

EV/EBITDA

Sector -57.74

Industry -57.74

EV/EBIT

Sector -289.61

Industry -289.61

P/EBITDA

-33.57

Sector -9.38

Industry -9.38

P/EBIT

-33.50

Sector -9.71

Industry -9.71

P/Total Assets

9.15

Sector 0.86

Industry 0.86

P/Net Current Assets

11.82

Sector -2.04

Industry -2.04

P/Working Capital

11.73

Sector -4,847.72

Industry -4,847.72

EPS

-0.41

Sector 0.73

Industry 0.73

BVPS

0.34

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

50.00%

Sector 35.14%

Industry 35.14%

EBITDA Margin

Sector 7.88%

Industry 7.88%

EBIT Margin

Sector -7.02%

Industry -7.02%

Operating Margin

100.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

100.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

Sector 0.11

Industry 0.11

Profitability

ROE

-121.15%

Sector 2.49%

Industry 2.49%

ROA

-96.89%

Sector -0.64%

Industry -0.64%

ROIC

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

5.00

Sector 1.46

Industry 1.46

Net Debt / EBITDA

Sector -20.28

Industry -20.28

Net Debt / EBIT

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

Sector -0.77

Industry -0.77

Gross Debt / Equity

Sector 0.06

Industry 0.06

Equity/Assets

0.80

Sector 0.43

Industry 0.43

Liabilities/Assets

0.20

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

7.17%

Sector -

Industry -

Fundamentals INTS

DRAG THE FRAME TO SEE MORE DATA

INTS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Intensity Therapeutics, Inc. Common stock

Intensity Therapeutics, Inc. Common stock

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2023

Time since IPO - 3 years

5

Employees

Intensity Therapeutics, Inc. Common stock (United States) is listed on the Nasdaq and has a market capitalization of $105.42 million, with shareholders equity totaling $9.21 million.

The company employs approximately 5 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Intensity Therapeutics, Inc. Common stock reported $-26.00 Thousand in revenue, generating net income of $-11.16 million.

Key financial metrics include a P/E ratio of -9.44, a price-to-book (P/B) ratio of 11.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INTS.

Market cap

$105.42 million

Net worth

$9.21 million

$9,214,000.00

Assets

$11.52 million

$11,521,000.00

Total Shares Outstanding

27.07 million

27,066,000

Average Daily Trading Volume

$40.28 Thousand

$40,280.00

Sector

Others

Industry

Others

INTS

INTS revenue and profits

Financial Results INTS

DRAG THE FRAME TO SEE MORE DATA

INTS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$374.03 14,05% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$94.75 38,99% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.82 --51,25% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$307.93 6,98% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$50.57 --9,44% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$90.89 58,75% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$92.61 5,71% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$407.90 32,76% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97